Zealand Pharma A/S | Income Statement
Fiscal year is January-December. All values DKK Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,574.00
153,773.00
187,677.00
234,778.00
139,775.00
37,977
Cost of Goods Sold (COGS) incl. D&A
6,783.00
19,708.00
28,482.00
36,869.00
19,386.00
7,864
Gross Income
209.00
134,065.00
159,195.00
197,909.00
120,389.00
30,113
SG&A Expense
192,711.00
213,930.00
253,350.00
315,252.00
367,380.00
477,249
EBIT
192,920.00
79,865.00
94,155.00
116,566.00
246,991.00
651,760
Unusual Expense
1,162.00
-
-
-
74.00
1,389
Non Operating Income/Expense
7,362.00
8,673.00
16,578.00
2,655.00
7,292.00
5,474
Interest Expense
-
2,017.00
42,394.00
40,781.00
25,610.00
35,052
Pretax Income
183,676.00
72,490.00
119,832.00
159,410.00
277,771.00
625,056
Income Tax
-
7,500.00
5,875.00
5,500.00
5,500.00
43,774
Consolidated Net Income
183,676.00
64,990.00
113,957.00
153,910.00
272,271.00
581,282
Net Income
183,676.00
64,990.00
113,957.00
153,910.00
272,271.00
581,282
Net Income After Extraordinaries
183,676.00
64,990.00
113,957.00
153,910.00
272,271.00
581,282
Net Income Available to Common
183,676.00
64,990.00
113,957.00
153,910.00
272,271.00
581,282
EPS (Basic)
8.10
2.87
4.82
6.33
9.77
18.94
Basic Shares Outstanding
22,628.80
22,628.80
23,639.40
24,309.70
27,854.00
30,690.70
EPS (Diluted)
8.12
2.87
4.82
6.33
9.77
18.94
Diluted Shares Outstanding
22,628.80
22,628.80
23,639.40
24,309.70
27,854.00
30,696.40
EBITDA
187,009.00
73,933.00
87,940.00
111,156.00
242,234.00
656,268
Other Operating Expense
-
-
-
777.00
-
1,098,896
Non-Operating Interest Income
3,044.00
719.00
139.00
592.00
2,048.00
4,263
About Zealand Pharma A/S
View Profile
